Document is current
Any future updates will be listed below
-
Authors
Imai, Masaki http://orcid.org/0000-0001-6988-1975
Yamashita, Makoto
Sakai-Tagawa, Yuko
Iwatsuki-Horimoto, Kiyoko http://orcid.org/0000-0002-8266-020X
Kiso, Maki
Murakami, Jurika
Yasuhara, Atsuhiro
Takada, Kosuke
Ito, Mutsumi
Nakajima, Noriko
Takahashi, Kenta
Lopes, Tiago J. S.
Dutta, Jayeeta
Khan, Zenab
Kriti, Divya http://orcid.org/0000-0002-9357-5588
van Bakel, Harm http://orcid.org/0000-0002-1376-6916
Tokita, Akifumi
Hagiwara, Haruhisa
Izumida, Naomi
Kuroki, Haruo
Nishino, Tamon
Wada, Noriyuki
Koga, Michiko
Adachi, Eisuke
Jubishi, Daisuke
Hasegawa, Hideki
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19fm0108006, JP19fk0108031, JP19fk0108058, JP19fk0108056, JP18am001007, JP19fk0108066)
Ministry of Education, Culture, Sports, Science and Technology (16H06429, 16K21723, 16H06434)
(CRIP, HHSN272201400008C)
-
License Information
Text and Data Mining valid from 2019-11-25
Version of Record valid from 2019-11-25
-
More Information
Article History
Received: 29 April 2019
Accepted: 11 October 2019
First Online: 25 November 2019
Competing interests
: M.Imai, Y.S.-T., K.I.-H., M.Kiso, J.M., A.Y., K.Takada, M.Ito, N.N., K.Takahashi, T.J.S.L., J.D., Z.K., D.K., H.V.B., A.T., H.Hagiwara, N.I., H.K., T.N., N.W., M.Koga, E.A., D.J. and H.Hasegawa have no competing interests. M.Y. has received a speaker’s honoraria from Daiichi Sankyo. Y.K. has received a speaker’s honoraria from Toyama Chemical and Astellas, grant support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Shionogi & Co and Kyoritsu Seiyaku, and is a founder of FluGen.
